Asda Vibhagool

2.0k total citations
38 papers, 1.4k citations indexed

About

Asda Vibhagool is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Asda Vibhagool has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 19 papers in Virology and 16 papers in Epidemiology. Recurrent topics in Asda Vibhagool's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (14 papers). Asda Vibhagool is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (14 papers). Asda Vibhagool collaborates with scholars based in Thailand, United States and Italy. Asda Vibhagool's co-authors include Somnuek Sungkanuparph, Wasun Chantratita, Ekachai Jenwitheesuk, Weerawat Manosuthi, Sasisopin Kiertiburanakul, Ammarin Thakkinstian, Narin Hiransuthikul, Woraphot Tantisiriwat, Prapaporn Boonma and Kiat Ruxrungtham and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Asda Vibhagool

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asda Vibhagool Thailand 18 906 500 479 195 102 38 1.4k
J Modaï France 20 622 0.7× 620 1.2× 232 0.5× 107 0.5× 46 0.5× 87 1.3k
Hung‐Chin Tsai Taiwan 22 748 0.8× 539 1.1× 165 0.3× 84 0.4× 68 0.7× 93 1.6k
Monique Keuter Netherlands 23 558 0.6× 285 0.6× 190 0.4× 64 0.3× 171 1.7× 43 1.3k
Sasheela Ponnampalavanar Malaysia 22 674 0.7× 348 0.7× 104 0.2× 115 0.6× 136 1.3× 97 1.5k
Chia‐Jui Yang Taiwan 19 400 0.4× 399 0.8× 103 0.2× 73 0.4× 27 0.3× 83 1.1k
Dan Oţelea Romania 18 1.2k 1.3× 450 0.9× 868 1.8× 26 0.1× 28 0.3× 64 1.6k
Ulrich Seybold Germany 14 898 1.0× 296 0.6× 97 0.2× 98 0.5× 49 0.5× 54 1.1k
Niccolò Riccardi Italy 20 610 0.7× 307 0.6× 99 0.2× 49 0.3× 45 0.4× 102 1.0k
Craig Conover United States 16 424 0.5× 309 0.6× 195 0.4× 39 0.2× 25 0.2× 25 990

Countries citing papers authored by Asda Vibhagool

Since Specialization
Citations

This map shows the geographic impact of Asda Vibhagool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asda Vibhagool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asda Vibhagool more than expected).

Fields of papers citing papers by Asda Vibhagool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asda Vibhagool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asda Vibhagool. The network helps show where Asda Vibhagool may publish in the future.

Co-authorship network of co-authors of Asda Vibhagool

This figure shows the co-authorship network connecting the top 25 collaborators of Asda Vibhagool. A scholar is included among the top collaborators of Asda Vibhagool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asda Vibhagool. Asda Vibhagool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Phumee, Atchara, Nopadon Noppakun, Asda Vibhagool, et al.. (2013). Detection of Leishmania siamensis DNA in Saliva by Polymerase Chain Reaction. American Journal of Tropical Medicine and Hygiene. 89(5). 899–905. 21 indexed citations
3.
Zhou, Jialun, Rossana Ditangco, Adeeba Kamarulzaman, et al.. (2007). Experience with the use of a first‐line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Medicine. 8(1). 8–16. 40 indexed citations
4.
Sungkanuparph, Somnuek, Weerawat Manosuthi, Sasisopin Kiertiburanakul, & Asda Vibhagool. (2005). Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand. Journal of Infection. 52(3). 188–194. 30 indexed citations
5.
Manosuthi, Weerawat, Somnuek Sungkanuparph, Ammarin Thakkinstian, et al.. (2005). Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin. AIDS. 19(14). 1481–1486. 62 indexed citations
6.
Zhou, Jialun, N. Kumarasamy, Rossana Ditangco, et al.. (2005). The TREAT Asia HIV Observational Database. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(2). 174–179. 89 indexed citations
7.
Manosuthi, Weerawat, Sasisopin Kiertiburanakul, Somnuek Sungkanuparph, et al.. (2005). Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results. AIDS. 20(1). 131–132. 81 indexed citations
8.
Sungkanuparph, Somnuek, et al.. (2005). Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability. International Journal of STD & AIDS. 16(3). 243–246. 11 indexed citations
9.
Squires, Kathleen, Adriano Lazzarin, William G. Powderly, et al.. (2004). Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(5). 1011–1019. 238 indexed citations
10.
Panburana, Panyu, Sayomporn Sirinavin, Winit Phuapradit, Asda Vibhagool, & Wasun Chantratita. (2004). Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1. American Journal of Obstetrics and Gynecology. 190(3). 803–808. 8 indexed citations
11.
Cahn, Pedro, Asda Vibhagool, Mauro Schechter, et al.. (2004). Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine. Current Medical Research and Opinion. 20(7). 1115–1123. 20 indexed citations
12.
13.
14.
Ananworanich, Jintanat, Reto Nüesch, Asda Vibhagool, et al.. (2003). Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS. 17(15). F33–F37. 75 indexed citations
15.
Jenwitheesuk, Ekachai, et al.. (2003). Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002. Annals of Clinical Microbiology and Antimicrobials. 2(1). 4–4. 10 indexed citations
16.
Vibhagool, Asda, Somnuek Sungkanuparph, Piroon Mootsikapun, et al.. (2003). Discontinuation of Secondary Prophylaxis for Cryptococcal Meningitis in Human Immunodeficiency Virus–Infected Patients Treated with Highly Active Antiretroviral Therapy: A Prospective, Multicenter, Randomized Study. Clinical Infectious Diseases. 36(10). 1329–1331. 87 indexed citations
17.
Critchley, Ian A., Renée S. Blosser-Middleton, Michael E. Jones, et al.. (2002). Antimicrobial Resistance among Respiratory Pathogens Collected in Thailand during 1999-2000. Journal of Chemotherapy. 14(2). 147–154. 3 indexed citations
18.
Jenwitheesuk, Ekachai, et al.. (2002). Prevalence of HIV-1 drug resistance in antiretroviral-naive pregnant Thai women.. PubMed. 33(4). 818–21. 3 indexed citations
19.
Chindavijak, Busba, et al.. (1999). Pharmacokinetics of levofloxacin in healthy Thai male volunteers.. PubMed. 82(11). 1127–35. 15 indexed citations
20.
Manion, Douglas J., Asda Vibhagool, Ting‐Chao Chou, et al.. (1996). Susceptibility of human cytomegalovirus to two-drug combinations in vitro.. PubMed. 1(4). 237–45. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Modaï Breakdown of academic impact, for papers by Hung‐Chin Tsai Breakdown of academic impact, for papers by Monique Keuter Breakdown of academic impact, for papers by Sasheela Ponnampalavanar Breakdown of academic impact, for papers by Chia‐Jui Yang Breakdown of academic impact, for papers by Dan Oţelea Breakdown of academic impact, for papers by Ulrich Seybold Breakdown of academic impact, for papers by Niccolò Riccardi Breakdown of academic impact, for papers by Craig Conover
Rankless by CCL
2026